- Page 1:
ASYMMETRIC STRATEGIES FOR THE SYNTH
- Page 6 and 7:
ACKNOWLEDGEMENTS First of all, I wa
- Page 8 and 9:
CONTENTS SYNOPSIS LIST OF FIGURES L
- Page 10:
SYNOPSIS
- Page 13 and 14:
models (e. g. Cram’s model, Felki
- Page 15 and 16:
4 1d 4-(CH 3 ) 2 CH-C 6 H 4 1 : 1.5
- Page 17 and 18:
14. 1n C 6 H 5 CO C 6 H 5 2n 8 77 1
- Page 19 and 20:
imetallic systems. In all the cases
- Page 21 and 22:
For the benzylation reaction, the c
- Page 23 and 24:
O O 3 CHO i O O + OH 13a O O OH O O
- Page 25 and 26:
10 3.5 Ga (2.5) THF KI+LiCl 10 55 5
- Page 27 and 28:
multidrug-resistant (MDR) cancer ce
- Page 29 and 30:
directly afforded the furanose, whi
- Page 31 and 32:
References 1. Stephenson, G. R. Adv
- Page 33 and 34:
LIST OF FIGURES
- Page 35 and 36:
II.3.13 III.1.1 III.1.2 III.1.3 III
- Page 37 and 38:
IV.5.2 IV.5.3 IV.5.4 IV.5.5 1 H NMR
- Page 39 and 40:
Table Title Page No. II.3.1 II.3.2
- Page 41 and 42:
II. .11 PPREAMBLE Demand for specia
- Page 43 and 44:
II. .22 IINTRODUCTIION TO CHIIRALII
- Page 45 and 46:
The most dramatic example in this a
- Page 47 and 48:
H H 2 N OH COOH i PhH 2 CO O H N H
- Page 49 and 50:
Methods of Asymmetric Synthesis: 15
- Page 51 and 52:
O O O O i, ii iii iv HO HO N N OH O
- Page 53 and 54:
Models for Asymmetric Synthesis. 21
- Page 55 and 56:
If a strongly electronegative group
- Page 57 and 58:
enantiomeric products are formed at
- Page 59 and 60:
vi) The balance between chiral auxi
- Page 61 and 62:
IIII. .11 IINTRODUCTIION TO CHIIRAL
- Page 63 and 64:
Scheme II.1.2 However, availability
- Page 65 and 66:
Prof. R. Noyori received the Nobel
- Page 67 and 68:
Apart from the cinchona alkaloids,
- Page 69 and 70:
ligand, it assumes a tetrahedral co
- Page 71 and 72:
Marshall. 53 More recently, Barbero
- Page 73 and 74:
Various protocols have been develop
- Page 75 and 76:
In the absence of a sterically-bulk
- Page 77 and 78:
IIII. .33. . PPRESSENT WORK It is w
- Page 79 and 80:
[pyridinium][Sn 2 Cl 5 ] etc. can b
- Page 81 and 82:
RCHO 59a-j i R OH 60a-j (i) Allyl b
- Page 83 and 84:
Fig. II.3.2. 1 H NMR spectrum of 60
- Page 85 and 86:
in [bmim][BF 4 ] using sub-stoichio
- Page 87 and 88:
The reaction in THF was also follow
- Page 89 and 90:
The integration of the signal at δ
- Page 91 and 92:
The standard reduction potential of
- Page 93 and 94:
It has also been reported, 83a,b th
- Page 95 and 96:
IIII. .33. .33 Gaal lliuum meeddi i
- Page 97 and 98:
5 3.0 5.0 THF LiCl+KI c 14 d 71 6 1
- Page 99 and 100:
3 59d 4-(CH 3 ) 2 CH-C 6 H 4 H 60d
- Page 101 and 102:
Fig. II.3.8. 13 C NMR spectrum of 6
- Page 103 and 104: Fig. II.3.10. 13 C NMR spectrum of
- Page 105 and 106: fragmentation peak at m/z 138 (19%)
- Page 107 and 108: Fig. II.3.13. 13 C NMR spectrum of
- Page 109 and 110: active catalyst, as suggested for t
- Page 111 and 112: 1-(4-Bromophenyl)-but-3-en-1-ol 59b
- Page 113 and 114: 1H), 7.90-7.93 (m, 1H); 13 C NMR:
- Page 115 and 116: 662, 980, 1079, 1332, 1374 cm -1 .
- Page 117 and 118: IIIIII. .11 DIIASSTEREOSSELECTIIVE
- Page 119 and 120: cyclohexylideneglyceraldehyde (1) 3
- Page 121 and 122: mixture of Zn dust, allyl or γ-sub
- Page 123 and 124: Fig. III.1.2. 13 C NMR spectrum of
- Page 125 and 126: Reaction with crotyl bromide: In ca
- Page 127 and 128: Fig. III.1.5. 1 H NMR spectrum of 6
- Page 129 and 130: The formation of the 2,3-anti addit
- Page 131 and 132: To establish the C-4 configuration
- Page 133 and 134: Allylation with (E) and (Z)-1-bromo
- Page 135 and 136: (i) Zn, aqueous satd. NH 4 Cl, THF,
- Page 137 and 138: Fig. III.1.12. 1 H NMR spectrum of
- Page 139 and 140: Allylation with 1-Bromo-4-(tert)-bu
- Page 141 and 142: fast and gave a significantly bette
- Page 143 and 144: espectively) due to the cyclohexyli
- Page 145 and 146: Fig. III.1.19. 13 C NMR spectrum of
- Page 147 and 148: was treated with excess amount of b
- Page 149 and 150: Fig. III.1.20. 1 H NMR spectrum of
- Page 151 and 152: Fig. III.1.22. 13 C NMR spectrum of
- Page 153: stereochemistry of allylation of β
- Page 157 and 158: 6 1.2 In (2.0) H 2 O LiCl+ KI 14 72
- Page 159 and 160: are consistent with our previous re
- Page 161 and 162: III.3 EXPERIMENTAL SECTION: General
- Page 163 and 164: (2R,3R)-1,2-Cyclohexylidenedioxy-5-
- Page 165 and 166: for an additional 2 h, gradually br
- Page 167 and 168: (m, 2H), 5.82-5.98 (m, 1H), 7.25-7.
- Page 169 and 170: 31.6, 32.2, 63.4, 128.8, 133.0. Ana
- Page 171 and 172: 23 (2R,3S,4R)-1,2-Cyclohexylidenedi
- Page 173 and 174: (2R,3S,4S)-1,2-Cyclohexylidenedioxy
- Page 175 and 176: (m, 1H), 3.50-4.02 (m, 5H), 4.10-4.
- Page 177 and 178: and dried. Removal of solvent in va
- Page 179 and 180: ine, and dried. Solvent removal und
- Page 181 and 182: IIV. .11 SSYNTHESSIISS OFF ENANTIIO
- Page 183 and 184: Scheme IV.1.1 The same group also d
- Page 185 and 186: IV.1.3: Present work Although sever
- Page 187 and 188: O O C 6 H 13 i O C 6 H 13 ii OH C 6
- Page 189 and 190: Fig. IV.1.4. 1 H NMR spectrum of 10
- Page 191 and 192: the unit-C contribute positively to
- Page 193 and 194: tartrate, Ti(O-i-Pr) 4 , CH 2 Cl 2
- Page 195 and 196: Based on this hypothesis, the alcoh
- Page 197 and 198: OR 3 O R 1 R 2 NaBH 4 H H R 1 R 1 +
- Page 199 and 200: (OH). Oxidative cleavage of its α-
- Page 201 and 202: Fig. IV.2.2. 1 H NMR spectrum of 13
- Page 203 and 204: Fig. IV.2.6. 1 H NMR spectrum of 14
- Page 205 and 206:
IIV. .33: : SSYNTHESSIISS OFF 33' '
- Page 207 and 208:
For the actual synthesis, (Scheme I
- Page 209 and 210:
Fig. IV.3.1. 1 H NMR spectrum of 14
- Page 211 and 212:
IV.4: SSYNTHESSIISS OFF 22( (SS) )-
- Page 213 and 214:
(i) PhCHO, triethyl orthoformate, M
- Page 215 and 216:
O N 3 II Ph HO OH b1 N 3 Ph O O Ben
- Page 217 and 218:
Fig. IV.4.2. 1 H NMR spectrum of 91
- Page 219 and 220:
Thus, easily accessible 1 has been
- Page 221 and 222:
167 and subsequent reduction gave 1
- Page 223 and 224:
from the appearance of 13 C NMR pea
- Page 225 and 226:
Fig. IV.5.2. 1 H NMR spectrum of 17
- Page 227 and 228:
IV.6 EXPERIMENTAL SECTION (2R,3S,4R
- Page 229 and 230:
As described earlier, compound 108
- Page 231 and 232:
19.5, 23.8, 23.9, 25.1, 26.9, 34.6,
- Page 233 and 234:
74.2, 74.4, 110.1, 116.7, 127.6, 12
- Page 235 and 236:
mmol) in MeOH (10 mL), work up, fol
- Page 237 and 238:
7.51 (m, 3H), 7.92-8.08 (m, 2H); 13
- Page 239 and 240:
subsequent isolation afforded rotam
- Page 241 and 242:
4.18 (t, J = 3.4 Hz, 1H), 4.75-4.84
- Page 243 and 244:
-4.21 (c 1.2, CHCl 3 ); IR: 3466, 1
- Page 245 and 246:
(3R)- 3,4-O-Cyclohexylidene-2-oxo-1
- Page 247 and 248:
Water and EtOAc was added to the mi
- Page 249 and 250:
24 179. Yield: 1.49 g (77.5%); colo
- Page 251 and 252:
24 furnished pure 183. Yield: 0.37
- Page 253 and 254:
1. Wender, P. A. Chem. Rev. 1996, 9
- Page 255 and 256:
17. Hanessian, S.; Maji, D. K.; Gov
- Page 257 and 258:
32. For some selective references s
- Page 259 and 260:
43. (a) Cleare, M. J.; Hydes, P. C.
- Page 261 and 262:
54. Barbero, A.; Pulido, F. J.; Rin
- Page 263 and 264:
2008, 1681. (d) Fargeas, V.; Zammat
- Page 265 and 266:
72. Karodia, N.; Guise, S.; Newland
- Page 267 and 268:
Kaminski, J.; Millhauser, G.; Ortiz
- Page 269 and 270:
Böhm, V. P. W.; Reisinger, C. J. O
- Page 271 and 272:
119. Wender, P. A.; Holt, D. A.; Si
- Page 273 and 274:
140. (a) Chemler, S. R.; Roush, W.
- Page 275 and 276:
Lett. 1996, 107, 53. (c) Smith, C.
- Page 277 and 278:
158. Mitsuya, H.; Weinhold, K. J.;
- Page 279 and 280:
L.; Zugay, J. A. J. Med. Chem. 1993
- Page 281 and 282:
1. Goswami, D.; Chattopadhyay, A.;